In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of SELLAS Life Sciences Group Inc (NASDAQ: SLS) closed at $1.49 in the last session, up 0.68% from day before closing price of $1.48. In other words, the price has increased by $0.68 from its previous closing price. On the day, 2.77 million shares were traded.
Ratios:
We take a closer look at SLS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.26. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.
On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.
Stock Price History:
Over the past 52 weeks, SLS has reached a high of $1.84, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is 37.78%, while the 200-Day Moving Average is calculated to be 21.77%.
Shares Statistics:
A total of 78.58M shares are outstanding, with a floating share count of 76.76M. Insiders hold about 2.32% of the company’s shares, while institutions hold 6.85% stake in the company.
